Sunshine Biopharma (SBFM) Finished Goods (2019 - 2020)
Sunshine Biopharma (SBFM) posted Finished Goods of $23771.0 for Q4 2020, up 49.41% on a QoQ basis from $15910.0 in Q4 2019, and up 49.41% year-over-year from $15910.0 in Q1 2020.
Sunshine Biopharma (SBFM) Finished Goods (2019 - 2020) Analysis & Trends
Sunshine Biopharma's Finished Goods history runs 2 years deep, the most recent figure standing at $23771.0 for Q4 2020.
- Quarterly Finished Goods rose 49.41% year-over-year to $23771.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $23771.0 (up 49.41% YoY) and the FY2020 annual result came in at $23771.0, up 49.41% from the prior year.
- Finished Goods was $23771.0 for Q4 2020 at Sunshine Biopharma, up from $15910.0 in the prior quarter.
- Across five years, Finished Goods topped out at $23771.0 in Q4 2020 and bottomed at $15910.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 23,771.00 |
| Dec 31, 2019 | 15,910.00 |